According to Terns Pharmaceuticals's latest financial reports the company's current earnings (TTM) are -$0.11 B. In 2022 the company made an earning of -$62.03 M a decrease over its 2021 earnings that were of -$49.86 M.The earnings displayed on this page is the company's Pretax Income.
Year | Earnings | Change |
---|---|---|
2023 (TTM) | -$0.11 B | 65.34% |
2022 | -$62.03 M | 24.41% |
2021 | -$49.86 M | 34.67% |
2020 | -$37.03 M |
Company | Earnings | Earnings differencediff. | Country |
---|---|---|---|
![]() ORIC Pharmaceuticals
ORIC | -$0.12 B | 9.87% | ๐บ๐ธ USA |